These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26086136)

  • 21. B cells biology in systemic lupus erythematosus-from bench to bedside.
    Zhao L; Ye Y; Zhang X
    Sci China Life Sci; 2015 Nov; 58(11):1111-25. PubMed ID: 26563177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study on immunological effects of L-canavanine.
    Morimoto I
    Kobe J Med Sci; 1989 Dec; 35(5-6):287-98. PubMed ID: 2635243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired accessory cell function of monocytes in systemic lupus erythematosus.
    Muryoi T; Sasaki T; Sekiguchi Y; Tamate E; Takai O; Yoshinaga K
    J Clin Lab Immunol; 1989 Mar; 28(3):123-8. PubMed ID: 2738910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent expression of autoantibodies in systemic lupus erythematosus.
    McCarty GA; Rice JR; Bembe ML; Pisetsky DS
    J Rheumatol; 1982; 9(5):691-5. PubMed ID: 6983576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
    Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
    J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'That Obscure Object of Desire': in systemic lupus erythematosus B-cell activating factor/B-lymphocyte stimulator is targeted both by the immune system and by physicians.
    Sanchez-Niño MD; Ortiz A
    Nephrol Dial Transplant; 2015 Mar; 30(3):394-400. PubMed ID: 24914092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro production of antihistone antibodies in systemic lupus erythematosus (SLE).
    Gioud-Paquet M; Martinon S; Bouvier M; Lejeune E; Monier JC
    Thymus; 1987; 9(2):127-9. PubMed ID: 3590273
    [No Abstract]   [Full Text] [Related]  

  • 29. Defective B cell tolerance checkpoints in systemic lupus erythematosus.
    Yurasov S; Wardemann H; Hammersen J; Tsuiji M; Meffre E; Pascual V; Nussenzweig MC
    J Exp Med; 2005 Mar; 201(5):703-11. PubMed ID: 15738055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies and SLE.
    Ziminski CM
    Md Med J; 1991 Oct; 40(10):901-8. PubMed ID: 1943519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nature, functions, and clinical implications of IgG4 autoantibodies in systemic lupus erythematosus and rheumatoid arthritis.
    Pan Q; Lan Q; Peng Y; Cai J; Zheng J; Dickerson C; Xiao H; Liu HF
    Discov Med; 2017 Mar; 23(126):169-174. PubMed ID: 28472610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical utility of anti-ribosomal P autoantibodies in systemic lupus erythematosus.
    Pasoto SG; Viana VS; Bonfa E
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1493-503. PubMed ID: 25292164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The study of the participation of basement membrane zone antibodies in the formation of the lupus band in systemic lupus erythematosus.
    Yang S; Gao Y; Song Y; Liu J; Yang C; Liu J; Wang Z; Zhang X
    Int J Dermatol; 2004 Jun; 43(6):420-7. PubMed ID: 15186222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recent aspects of selected autoantibodies in patients with systemic lupus erythematodes and their clinical significance. III. RNA-fixing autoantibodies, ribonucleoprotein autoantibodies].
    Wollina U
    Allerg Immunol (Leipz); 1983; 29(4):191-9. PubMed ID: 6198890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical significance of autoantibodies to soluble cellular antigens in systemic lupus erythematosus.
    Asero R; Bertetti E; Origgi L; Riboldi P; Zanussi C
    J Clin Lab Immunol; 1990 Mar; 31(3):115-9. PubMed ID: 1966995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased binding of circulating systemic lupus erythematosus autoantibodies to recombinant interferon alpha 2b.
    Khan WA; Qureshi JA
    APMIS; 2015 Dec; 123(12):1016-24. PubMed ID: 26547367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Link-Polymorphism of 5-HTT Promoter Region Is Associated with Autoantibodies in Patients with Systemic Lupus Erythematosus.
    Li S; Liu S; Chen F; Cheng Y; Bai R; Lai A; Lu Z; Xu J
    J Immunol Res; 2016; 2016():3042726. PubMed ID: 27819008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical systemic lupus erythematosus.
    Robertson JM; James JA
    Rheum Dis Clin North Am; 2014 Nov; 40(4):621-35. PubMed ID: 25437281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.